Liu Wei, Yu Chengpeng, Li Jianfeng, Fang Jiwei
Department of Geriatrics, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Second Clinical Medical College, Nanchang University, Nanchang, China.
Front Cell Dev Biol. 2022 Feb 10;10:788587. doi: 10.3389/fcell.2022.788587. eCollection 2022.
The erythropoietin-producing hepatocellular carcinoma (Eph) receptors and their Eph receptor-interacting (ephrin) ligands together constitute a vital cell communication system with diverse roles. Experimental evidence revealed Eph receptor bidirectional signaling with both tumor-promoting and tumor-suppressing activities in different cancer types and surrounding environment. Eph receptor B2 (EphB2), an important member of the Eph receptor family, has been proved to be aberrantly expressed in many cancer types, such as colorectal cancer, gastric cancer and hepatocellular carcinoma, resulting in tumor occurrence and progression. However, there are no reviews focusing on the dual roles of EphB2 in cancer. Thus, in this paper we systematically summarize and discuss the roles of EphB2 in cancer. Firstly, we review the main biological features and the related signaling regulatory mechanisms of EphB2, and then we summarize the roles of EphB2 in cancer through current studies. Finally, we put forward our viewpoint on the future prospects of cancer research focusing on EphB2, especially with regard to the effects of EphB2 on tumor immunity.
促红细胞生成素产生性肝细胞癌(Eph)受体及其与Eph受体相互作用的(ephrin)配体共同构成了一个具有多种作用的重要细胞通讯系统。实验证据表明,Eph受体在不同癌症类型和周围环境中具有双向信号传导,兼具促肿瘤和抑肿瘤活性。Eph受体家族的重要成员Eph受体B2(EphB2)已被证明在许多癌症类型中异常表达,如结直肠癌、胃癌和肝细胞癌,导致肿瘤的发生和进展。然而,目前尚无聚焦于EphB2在癌症中双重作用的综述。因此,在本文中,我们系统地总结并讨论了EphB2在癌症中的作用。首先,我们回顾了EphB2的主要生物学特征及其相关信号调节机制,然后通过当前研究总结了EphB2在癌症中的作用。最后,我们对聚焦于EphB2的癌症研究的未来前景,尤其是EphB2对肿瘤免疫的影响,提出了我们的观点。